Enzalutamide and antiretroviral drugs: a challenge for clinicians
Enzalutamide is a non-steroidal anti-androgen for metastatic prostate cancer. It has a consistent influence on several cytochromes’ activity; therefore, co-administration of ART (antiretroviral therapy) is strongly contraindicated considering the high risk of virological failure. We are describing...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Verduci Editore
2021-09-01
|
| Series: | Infectious Diseases and Tropical Medicine |
| Subjects: | |
| Online Access: | https://www.infectiousjournal.com/wp-content/uploads/sites/6/2021/09/e750.pdf |